Ulrich Andergassen Selected Research

Ulrich Andergassen Research Topics

Disease

27	Breast Neoplasms (Breast Cancer) 10/2020 - 01/2010
21	Neoplasms (Cancer) 10/2020 - 01/2010
12	Circulating Neoplastic Cells 10/2018 - 01/2012
5	Neoplasm Metastasis (Metastasis) 05/2017 - 01/2015
3	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2019 - 12/2015
3	Carcinoma (Carcinomatosis) 06/2016 - 12/2012
3	Prostatic Neoplasms (Prostate Cancer) 10/2015 - 05/2013
2	Adenocarcinoma 09/2016 - 09/2016
1	Cardiotoxicity 01/2017
1	Choriocarcinoma 01/2016
1	Trophoblastic Neoplasms (Trophoblastic Tumor) 01/2016
1	Carcinogenesis 01/2015
1	Residual Neoplasm 09/2013
1	Disease Progression 05/2013
1	Endometriosis 01/2013
1	Ovarian Diseases (Ovarian Disease) 12/2012
1	Obesity 01/2010

Drug/Important Bio-Agent (IBA)

8	Hormones (Hormone)IBA 10/2020 - 01/2012
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2010
4	AnthracyclinesIBA 10/2020 - 08/2012
3	Gemcitabine FDA Link 10/2020 - 09/2015
3	Zoledronic Acid (Zometa)FDA Link 01/2019 - 01/2016
3	Estrogen ReceptorsIBA 09/2016 - 10/2014
3	RNA (Ribonucleic Acid)IBA 09/2016 - 01/2013
3	GlycosyltransferasesIBA 05/2016 - 01/2015
3	human ERBB2 proteinIBA 01/2016 - 12/2015
3	taxaneIBA 09/2015 - 08/2012
2	Tumor Biomarkers (Tumor Markers)IBA 01/2018 - 01/2013
2	Phosphotransferases (Kinase)IBA 11/2017 - 01/2016
2	Complementary DNA (cDNA)IBA 09/2016 - 03/2013
2	SteroidsIBA 09/2016 - 01/2016
2	ParaffinIBA 09/2016 - 01/2016
2	Galectin 3 (LGALS3)IBA 06/2016 - 04/2016
2	AntigensIBA 06/2016 - 05/2013
2	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 04/2016 - 01/2016
2	Docetaxel (Taxotere)FDA Link 01/2016 - 06/2015
2	Messenger RNA (mRNA)IBA 03/2013 - 01/2013
1	Taxoids (Taxanes)IBA 10/2020
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2019
1	exemestane (Aromasin)FDA Link 01/2018
1	Tamoxifen FDA LinkGeneric 01/2018
1	Adenosine Triphosphate (ATP)IBA 11/2017
1	Adenosine Monophosphate (AMP)IBA 11/2017
1	CateninsIBA 05/2017
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2016
1	Interleukin-4 (Interleukin 4)IBA 06/2016
1	Interleukin-6 (Interleukin 6)IBA 06/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2016
1	Galectin 2 (LGALS2)IBA 04/2016
1	Galectin 1 (LGALS1)IBA 04/2016
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2016
1	Fluorouracil (Carac)FDA LinkGeneric 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016
1	Epirubicin (Ellence)FDA LinkGeneric 01/2016
1	tyrosine receptor (receptor, tyrosine)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Janus Kinase 2IBA 01/2016
1	Galectins (Galectin)IBA 12/2015
1	Phenobarbital (Luminal)FDA Link 09/2015
1	Epidermal Growth Factor (EGF)IBA 09/2015
1	CarbohydratesIBA 01/2015
1	hydrogen sulfite (bisulfite)IBA 10/2014
1	DNA (Deoxyribonucleic Acid)IBA 10/2014
1	Keratins (Keratin)IBA 08/2014
1	Cadherins (E-Cadherin)IBA 08/2014
1	LipocalinsIBA 03/2014
1	GlycodelinIBA 03/2014
1	Thomsen-Friedenreich antigenIBA 05/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2013
1	Hemoglobins (Hemoglobin)IBA 05/2013
1	Alkaline PhosphataseIBA 05/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Estrogens (Estrogen)FDA Link 01/2013
1	AntibodiesIBA 12/2012
1	Mucin-1 (CA 15-3 Antigen)IBA 12/2012
1	Trastuzumab (Herceptin)FDA Link 02/2012

Therapy/Procedure

8	Adjuvant Chemotherapy 10/2020 - 01/2012
8	Therapeutics 06/2016 - 01/2012
7	Drug Therapy (Chemotherapy) 10/2020 - 05/2014
2	Castration 06/2015 - 05/2013
1	Prostatectomy (Retropubic Prostatectomy) 10/2015
1	Neoadjuvant Therapy 10/2015